High cost keeps life-changing Alzheimer’s drug from Saratoga County family
The FDA granted accelerated approval earlier this month for a drug that’s designed to treat Alzheimer’s. Leqembi is for patients confirmed to be in early stage Alzheimer’s. While the approval is exciting, it’s limited to many.
For people living with Alzheimer’s, every second, every minute, every hour, every day counts. That includes a Saratoga County man – Chris Davies.
Cheri Davies has watched for the past four years, as Alzheimer’s slowly destroys her husband’s memory.
Chris Davies was diagnosed with younger-onset Alzheimer’s at the age of 50. As a husband and father, he knows the importance of more time. That’s why he and Cheri hope this new drug, Leqembi, gives them just that.
However, trying the drug out isn’t an option right now for the Davies. Without insurance and Medicare of this class of treatments, access to Leqembi is limited to only those who can afford to pay out of pocket. So the Alzheimer’s Association says it’s going to fight for its patients.
Learn about the huge price the drug could cost families out of pocket by watching the video of Faith King’s story.